[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369417-105":59,"doc-detail-369417-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","rad51-expression-and-prognostic-impact-in-patients-with-stomach-adenocarcinoma","RAD51 expression and prognostic impact in patients with stomach adenocarcinoma","","Stomach adenocarcinoma (STAD) has high incidence and mortality, and improved molecular biomarkers are needed to better predict patient outcomes. RAD51 is a central catalyst of homologous recombination that supports genomic integrity, yet its clinical significance in STAD remains unclear. This study integrates bioinformatic analyses and immunohistochemistry to examine RAD51 expression, diagnostic performance, clinicopathological associations, co-expression networks, and relationships with immune infiltration.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rad51-expression-and-prognostic-impact-in-patients-with-stomach-adenocarcinoma/369417/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rad51-expression-and-prognostic-impact-in-patients-with-stomach-adenocarcinoma/369417.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal regarding RAD51 in stomach adenocarcinoma?","Question",{"text":112,"@type":113},"To determine how RAD51 expression relates to clinicopathological features and patient outcomes in STAD, including its potential as a prognostic biomarker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was RAD51 expression measured and validated in STAD patients?",{"text":117,"@type":113},"RAD51 mRNA levels were assessed using UALCAN and GEPIA, diagnostic value was evaluated with ROC analysis based on TCGA, and protein expression was examined using immunohistochemistry.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between RAD51 expression and patient prognosis?",{"text":121,"@type":113},"High RAD51 expression was associated with significantly reduced overall survival, and multivariate analysis suggested RAD51 expression as an independent indicator of poor prognosis.",{"name":123,"@type":110,"acceptedAnswer":124},"Did RAD51 co-expression relate to immune cell infiltration in STAD?",{"text":125,"@type":113},"Yes. The study reported that RAD51 and its main co-expressed genes were significantly negatively associated with most or all immune cell infiltration.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369417,1790573388,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Submitted 24 July 2024  \nAccepted 25 February 2025  \nPublished 11 April 2025  \nCorresponding author  \nJicheng Liu, [jcliu23@sina.com](jcliu23@sina.com)  \nAcademic editor Vladimir Uversky  \nAdditional Information and Declarations can be found on page 13  \nDOI 10.7717/peerj.19179  \n Copyright 2025 Jian et al.  \nDistributed under  \nCreative Commons CC-BY-NC 4.0  \nOPEN ACCESS  \nRAD51 expression and prognostic impact in patients with stomach adenocarcinoma  \nBaiyu Jian1 ,2 ,* , Hao Zhang1 ,* , Li Fan1 , Yang Li1 , Nan Wu1 , Ningning Wang1 , Lingmin Li1 , Xueyan Li1 , Pengling Ge2 , Yingcai Niu1 and Jicheng Liu1  \n1 Qiqihar Medical University, Qiqihar, China  \n2 Heilongjiang University of Chinese Medicine, Harbin, China  \n* These authors contributed equally to this work.  \nABSTRACT  \nBackground. Stomach adenocarcinoma (STAD) is the most common gastrointestinal cancer. A clear diagnosis and molecular targeted therapy have important implications for prolonging survival of patients. RAD51 is the central catalyst of homologous recombination that plays important role in maintaining genomic integrity. However, the clinical significance of RAD51 expression in STAD patients remains unclear. This study aimed to assess the association of RAD51 expression with clinicopathological characteristics and patient outcomes.  \nMethods. In this study, RAD51 mRNA expression in STAD patients was assessed using the UALCAN and GEPIA databases. The diagnostic value of RAD51 was evaluated by analyzing the ROC curve (data from the The Cancer Genome Atlas (TCGA) database) . The protein expression level of RAD51 in STAD patients and its relationship with clinicopathological characteristics and prognosis were evaluated by immunohistochemistry. Co-expression analysis of RAD51 in STAD was performed by Coexpedia and Gene Expression Profiling Interactive Analysis (GEPIA) databases. The associations of RAD51 and its co-expression genes with immune infiltrates were analyzed in TIMER database.  \nResults. Our bioinformatic analysis revealed that RAD51 demonstrates elevated expression in STAD. The ROC curve analysis yielded anAUC value of 0.9366 (95% CI [0.9075􀀕 0.9658]), confirming its potential as a biomarker for STAD. Immunohistochemical assessments validated the up-regulation of RAD51 in STAD, highlighting its significant correlation with TNM stage and T stage, but not with age, sex, grade, N stage, M stage, or P53 expression. Patients exhibiting high RAD51 expression exhibited significantly reduced overall survival. Multivariate analysis identified RAD51 expression may serve as an independent prognostic biomarker of poor prognosis in patients with STAD. Additionally, our bioinformatic analysis identified eight RAD51 co-expression genes (AURKA, CKS1B, NUSAP1, PFDN4, CCNE1, CDCA4, KIF4A, and MCM10) in STAD. Moreover, we discovered that RAD51 and its main co-expressed genes were significantly negatively associated with most or all immune cell infiltration.  \nConclusions. RAD51 overexpression was related to disease progression and poor prognosis, as well as infiltration of immune cells in gastric cancer.  \nSubjects Biochemistry, Bioinformatics, Cell Biology, Oncology  \nKeywords Stomach neoplasms, RAD51 protein, Biomarkers, Prognosis  \nHow to cite this article Jian B, Zhang H, Fan L, Li Y, Wu N, Wang N, Li L, Li X, Ge P, Niu Y, Liu J. 2025. RAD51 expression and prognostic impact in patients with stomach adenocarcinoma. PeerJ 13:e19179 [http://doi.org/10.7717/peerj.19179](http://doi.org/10.7717/peerj.19179)  \nBACKGROUND  \nStomach adenocarcinoma (STAD) is the most common digestive tract tumor with a high incidence and mortality rate (Zhao, Zhang & Sun, 2022) . Despite improvements in the clinical treatment of STAD in recent years, the survival rate of patients with STAD remains very low, this is largely due to the paucity of effective methods to evaluate the prognosis of STAD patients (Guo et al., 2020b) .  \nDNA double-strand breaks (DSBs) are considered the most toxic for","cbCaiff9dBVntze7","https://ap.wps.com/l/cbCaiff9dBVntze7","pdf",45913657,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Disease context and need for biomarkers\n## DNA damage repair and homologous recombination\n## Role and regulation of RAD51 in cancer","[{\"question\":\"What is the study’s main goal regarding RAD51 in stomach adenocarcinoma?\",\"answer\":\"To determine how RAD51 expression relates to clinicopathological features and patient outcomes in STAD, including its potential as a prognostic biomarker.\"},{\"question\":\"How was RAD51 expression measured and validated in STAD patients?\",\"answer\":\"RAD51 mRNA levels were assessed using UALCAN and GEPIA, diagnostic value was evaluated with ROC analysis based on TCGA, and protein expression was examined using immunohistochemistry.\"},{\"question\":\"What relationship did the study find between RAD51 expression and patient prognosis?\",\"answer\":\"High RAD51 expression was associated with significantly reduced overall survival, and multivariate analysis suggested RAD51 expression as an independent indicator of poor prognosis.\"},{\"question\":\"Did RAD51 co-expression relate to immune cell infiltration in STAD?\",\"answer\":\"Yes. The study reported that RAD51 and its main co-expressed genes were significantly negatively associated with most or all immune cell infiltration.\"}]","RAD51 expression and prognostic impact in patients with stomach adenocarcinoma | PDF",1790182562,45,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/348a3ec7425735e074db520d1da7503c.webp",983,1272,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/913382e4e89e9642534104f7c8dedc3f.webp",982,1270,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b40023c5bf87d17dc97bc89934c5ab6.webp",981,1269,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40f0d9a5d28a19c17f3c514a49192904.webp",980,1268]